Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
5/22/2013 Kaufmann Michael C CEO, Pharmaceutical Segment -36 $47.52 -100.00%
5/22/2013 NOTEBAERT RICHARD C Director -3,197 $48.10 -9.31%
5/22/2013 NOTEBAERT RICHARD C Director 3,254 $46.49 10.47%
5/20/2013 SPAULDING JEAN G Director -1,666 $47.90 -8.93%
5/20/2013 Morford Craig S Chief Legal/Compliance Officer -45,994 $48.00 -32.55%
5/20/2013 WATKINS CAROLE S Chief HR Officer 6,494 $22.90 15.58%
5/20/2013 WATKINS CAROLE S Chief HR Officer -4,612 $48.00 -9.57%
5/20/2013 Morford Craig S Chief Legal/Compliance Officer 60,441 $27.29 74.73%
5/14/2013 COX CARRIE SMITH Director 435 $46.25 3.18%
5/8/2013 Morford Craig S Chief Legal/Compliance Officer 30,221 $27.29 39.64%
5/8/2013 Morford Craig S Chief Legal/Compliance Officer -24,070 $46.19 -22.61%
5/7/2013 WATKINS CAROLE S Chief HR Officer -25,592 $45.95 -38.04%
5/7/2013 WATKINS CAROLE S Chief HR Officer 5,284 $22.90 8.52%
5/7/2013 Blake Mark R EVP - Strategy & Corp. Dev. 38,350 $27.91 213.59%
5/7/2013 Morford Craig S Chief Legal/Compliance Officer 30,221 $27.29 43.12%
5/7/2013 Morford Craig S Chief Legal/Compliance Officer -24,070 $46.06 -24.00%
5/7/2013 Blake Mark R EVP - Strategy & Corp. Dev. -30,825 $46.00 -54.75%
5/6/2013 NOTEBAERT RICHARD C Director 2,205 $43.21 7.09%
5/6/2013 SPAULDING JEAN G Director 2,401 $39.69 8.99%
5/6/2013 SPAULDING JEAN G Director 3,044 $39.69 12.86%
5/6/2013 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -14,253 $46.14 -26.48%
5/6/2013 NOTEBAERT RICHARD C Director -5,001 $46.25 -13.86%
5/6/2013 Henderson Jeffrey William Chief Financial Officer 98,895 $41.10 89.98%
5/6/2013 NOTEBAERT RICHARD C Director 2,796 $43.21 8.40%
5/6/2013 Henderson Jeffrey William Chief Financial Officer -207,918 $46.18 -65.91%
5/6/2013 SPAULDING JEAN G Director -10,447 $46.19 -35.89%
5/6/2013 Henderson Jeffrey William Chief Financial Officer 106,636 $27.29 51.07%
5/6/2013 SPAULDING JEAN G Director 5,002 $43.21 26.80%
4/16/2013 Casey Donald M Jr. CEO, Medical Segment -249 $43.01 -0.83%
1/23/2013 Kaufmann Michael C CEO, Pharmaceutical Segment -58,362 $44.95 -35.87%
1/23/2013 Kaufmann Michael C CEO, Pharmaceutical Segment 55,158 $27.29 51.29%
1/23/2013 Morford Craig S Chief Legal/Compliance Officer -47,274 $45.00 -40.28%
1/23/2013 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -39,080 $45.00 -42.06%
1/23/2013 Morford Craig S Chief Legal/Compliance Officer 60,441 $27.29 106.18%
1/23/2013 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. 49,965 $27.29 116.35%
1/14/2013 WATKINS CAROLE S Chief HR Officer 643 $22.90 1.02%
1/14/2013 WATKINS CAROLE S Chief HR Officer -509 $43.06 -0.80%
1/10/2013 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. 49,965 $27.29 152.11%
1/10/2013 Blake Mark R EVP - Strategy & Corp. Dev. -1,471 $42.92 -7.57%
1/10/2013 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -39,867 $43.00 -48.14%
12/14/2012 Blake Mark R EVP - Strategy & Corp. Dev. -2,330 $42.25 -10.71%
11/1/2012 LAWS STUART G SVP & Chief Accounting Officer -2,564 $41.22 -33.24%
10/15/2012 Blake Mark R EVP - Strategy & Corp. Dev. -1,095 $40.89 -4.79%
10/4/2012 Henderson Jeffrey William Chief Financial Officer 50,000 $27.29 47.11%
10/4/2012 Henderson Jeffrey William Chief Financial Officer -46,226 $40.00 -29.61%
9/15/2012 WATKINS CAROLE S Chief HR Officer -1,291 $38.37 -2.01%
9/15/2012 Henderson Jeffrey William Chief Financial Officer -4,143 $38.37 -3.76%
9/15/2012 Morford Craig S Chief Legal/Compliance Officer -210 $38.37 -0.37%
9/15/2012 Barrett George S Chairman and CEO -21,881 $38.37 -5.63%
9/15/2012 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -763 $38.37 -2.27%
9/15/2012 Kaufmann Michael C CEO, Pharmaceutical Segment -382 $38.37 -0.35%
9/15/2012 LAWS STUART G SVP & Chief Accounting Officer -306 $38.37 -3.82%
9/10/2012 Henderson Jeffrey William Chief Financial Officer 50,000 $27.29 36.40%
9/10/2012 Henderson Jeffrey William Chief Financial Officer -77,081 $38.29 -41.14%
9/7/2012 Henderson Jeffrey William Chief Financial Officer -2,329 $39.39 -100.00%
8/16/2012 WATKINS CAROLE S Chief HR Officer -1,139 $38.81 -1.74%
8/16/2012 Morford Craig S Chief Legal/Compliance Officer -185 $39.81 -0.32%
8/16/2012 Kaufmann Michael C CEO, Pharmaceutical Segment -349 $39.81 -0.32%
8/16/2012 Blake Mark R EVP - Strategy & Corp. Dev. -692 $39.81 -2.94%
8/16/2012 Barrett George S Chairman and CEO -11,037 $39.81 -2.76%
8/16/2012 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -103 $39.81 -0.31%
8/16/2012 Henderson Jeffrey William Chief Financial Officer -2,783 $39.81 -1.99%
8/16/2012 LAWS STUART G SVP & Chief Accounting Officer -270 $39.81 -3.26%
8/15/2012 Kaufmann Michael C CEO, Pharmaceutical Segment -2,002 $39.77 -1.81%
8/15/2012 Blake Mark R EVP - Strategy & Corp. Dev. -528 $39.77 -2.19%
8/15/2012 Barrett George S Chairman and CEO -6,827 $39.77 -1.68%
8/15/2012 Henderson Jeffrey William Chief Financial Officer -2,231 $39.77 -1.57%
8/15/2012 Morford Craig S Chief Legal/Compliance Officer -139 $39.77 -0.24%
8/15/2012 WATKINS CAROLE S Chief HR Officer -830 $39.77 -1.25%
8/15/2012 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -84 $39.77 -0.25%
8/15/2012 LAWS STUART G SVP & Chief Accounting Officer -196 $39.77 -2.31%
5/17/2012 SPAULDING JEAN G Director -8,135 $42.06 -34.78%
5/17/2012 SPAULDING JEAN G Director 9,801 $28.80 72.12%
2/27/2012 Lynch Michael A CEO, Medical Segment -31,373 $42.00 -26.02%
2/27/2012 Lynch Michael A CEO, Medical Segment 39,400 $27.29 48.54%
2/24/2012 Lynch Michael A CEO, Medical Segment -40,173 $41.59 -33.11%
2/24/2012 Lynch Michael A CEO, Medical Segment 31,941 $32.33 35.72%
2/24/2012 Lynch Michael A CEO, Medical Segment 232 $22.90 0.26%
10/27/2011 Kaufmann Michael C CEO, Pharmaceutical Segment 53,158 $27.29 67.59%
10/27/2011 Kaufmann Michael C CEO, Pharmaceutical Segment -41,164 $44.95 -31.23%
10/26/2011 Kaufmann Michael C CEO, Pharmaceutical Segment -2,000 $44.95 -2.48%
10/26/2011 Kaufmann Michael C CEO, Pharmaceutical Segment 2,000 $27.29 2.54%
10/19/2011 LAWS STUART G SVP & Chief Accounting Officer -1,341 $42.40 -17.34%
10/15/2011 Blake Mark R EVP - Strategy & Corp. Dev. -1,095 $42.09 -5.49%
9/15/2011 Lynch Michael A CEO, Medical Segment -3,017 $41.58 -3.27%
9/15/2011 LAWS STUART G SVP & Chief Accounting Officer -305 $41.58 -3.79%
9/15/2011 Morford Craig S Chief Legal/Compliance Officer -210 $41.58 -0.45%
9/15/2011 Barrett George S Chairman and CEO -21,880 $41.58 -6.10%
9/15/2011 WATKINS CAROLE S Chief HR Officer -1,593 $41.58 -2.70%
9/15/2011 Kaufmann Michael C CEO, Pharmaceutical Segment -444 $41.58 -0.56%
9/15/2011 Henderson Jeffrey William Chief Financial Officer -4,143 $41.58 -3.30%
9/15/2011 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -763 $41.58 -2.63%
9/14/2011 LAWS STUART G SVP & Chief Accounting Officer -1,191 $41.14 -12.90%
8/17/2011 LAWS STUART G SVP & Chief Accounting Officer -1,100 $41.73 -10.65%
8/16/2011 Stephen Falk T EVP, Gen. Counsel & Corp. Sec. -103 $41.60 -0.35%
8/16/2011 LAWS STUART G SVP & Chief Accounting Officer -269 $41.60 -2.54%
8/16/2011 Lynch Michael A CEO, Medical Segment -2,349 $41.60 -2.48%
8/16/2011 Kaufmann Michael C CEO, Pharmaceutical Segment -405 $41.60 -0.51%
8/16/2011 WATKINS CAROLE S Chief HR Officer -1,139 $41.60 -1.89%
8/16/2011 Barrett George S Chairman and CEO -11,390 $41.60 -3.08%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (CAH), click here.
Marketplace
Trading Center